Projected Return Density against MarketGiven investment horizon of 30 days, Salix has beta of 0.71 . This entails as returns on market go up, Salix avarage returns are expected to increase less than the benchmark. However during bear market, the loss on holding Salix Pharmaceuticals Ltd will be expected to be much smaller as well. Additionally, Salix Pharmaceuticals Ltd has negative alpha implying that risk taken by holding this equity is not justified. The company is significantly underperforming S&P 500 Given investment horizon of 30 days, the coefficient of variation of Salix is -9054.43. The daily returns are destributed with a variance of 1.61 and standard deviation of 1.27. The mean deviation of Salix Pharmaceuticals Ltd is currently at 0.86. For similar time horizon, the selected benchmark (S&P 500) has volatility of 0.45
Actual Return VolatilitySalix Pharmaceuticals Ltd inherits 1.27% risk (volatility on return distribution) over the 30 days horizon. S&P 500 shows 0.45% volatility of returns over 30 trading days.
Follow Salix Volatility with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Salix Pharmaceuticals Ltd has a volatility of 1.27 and is 2.82 times more volatile than S&P 500. 13% of all equities and portfolios are less risky than Salix. Compared with the overall equity markets, volatility of historical daily returns of Salix Pharmaceuticals Ltd is lower than 13 (%) of all global equities and portfolios over the last 30 days. Use Salix Pharmaceuticals Ltd to protect against small markets fluctuations. The stock experiences somewhat bearish sentiment, but market may correct it shortly. Check odds of Salix to be traded at $82.35 in 30 days. As returns on market increase, Salix returns are expected to increase less than the market. However during bear market, the loss on holding Salix will be expected to be smaller as well.
Salix correlation with market
Salix Current Risk Indicators
Suggested Divercification Pairs